Two Ways of Targeting a CD19 Positive Relapse of Acute Lymphoblastic Leukaemia after Anti-CD19 CAR-T Cells.

Grain, Audrey; Ollier, Jocelyn; Guillaume, Thierry; Chevallier, Patrice; Le Calvez, Baptiste; Eveillard, Marion; Clémenceau, Béatrice

Grain, Audrey; Ollier, Jocelyn; Guillaume, Thierry; Chevallier, Patrice; Le Calvez, Baptiste; Eveillard, Marion; Clémenceau, Béatrice.

Afiliación

Grain A; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, F-44007 Nantes, France.
Ollier J; Paediatric Haematology and Oncology Nantes University Hospital, 44093 Nantes, France.
Guillaume T; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, F-44007 Nantes, France.
Chevallier P; Haematology Department, Nantes University Hospital, 44093 Nantes, France.
Le Calvez B; Haematology Department, Nantes University Hospital, 44093 Nantes, France.
Eveillard M; Haematology Department, Nantes University Hospital, 44093 Nantes, France.
Clémenceau B; Haematology Biology Department, Nantes University Hospital, 44093 Nantes, France.

Biomedicines ; 11(2)2023 Jan 25.

Article en En | MEDLINE | ID: mdl-36830882

Palabras clave

CAR-T cells; acute lymphoblastic leukaemia; immunotherapy; relapse

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomedicines Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google